The latest quarterly R&D expense is $11.54 Million with a QoQ Growth of +64.90%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $11.54M.
$11.54M
$11.54 Million
Q2 FY2026 · 2026-06-30
+64.90%
vs. $7.00M prior quarter
18
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $11.54M | +64.90% | +59.15% |
| Q1 FY2026Period end 2026-03-31 | $7.00M | +3.88% | -54.41% |
| Q4 FY2025Period end 2025-12-31 | $6.73M | -30.79% | -52.63% |
| Q3 FY2025Period end 2025-09-30 | $9.73M | +34.24% | -23.10% |
| Q2 FY2025Period end 2025-06-30 | $7.25M | -52.76% | +14.81% |
| Q1 FY2025Period end 2025-03-31 | $15.34M | +7.92% | +191.56% |
| Q4 FY2024Period end 2024-12-31 | $14.22M | +12.35% | +151.34% |
| Q3 FY2024Period end 2024-09-30 | $12.65M | +100.43% | +155.20% |
| Q2 FY2024Period end 2024-06-30 | $6.31M | +19.97% | +35.01% |
| Q1 FY2024Period end 2024-03-31 | $5.26M | -6.97% | +17.27% |
| Q4 FY2023Period end 2023-12-31 | $5.66M | +14.08% | -3.27% |
| Q3 FY2023Period end 2023-09-30 | $4.96M | +6.03% | -27.49% |
| Q2 FY2023Period end 2023-06-30 | $4.68M | +4.21% | -26.60% |
| Q1 FY2023Period end 2023-03-31 | $4.49M | -23.26% | -23.47% |
| Q4 FY2022Period end 2022-12-31 | $5.85M | -14.49% | N/A |
| Q3 FY2022Period end 2022-09-30 | $6.84M | +7.33% | N/A |
| Q2 FY2022Period end 2022-06-30 | $6.37M | +8.66% | N/A |
| Q1 FY2022Period end 2022-03-31 | $5.86M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
